Mitochondrial dysfunction, a new marker warning of neuropsychiatric disorder risk: evidence from genetics and epidemiology
The mitochondrial function biomarkers mtDNA-CN and MMA are expected to be potential therapeutic targets for depression and cognitive dysfunction, emphasizing the need for mitochondrial function monitoring and interventions in future therapies targeting neuropsychiatric disorders.
Authors
- Qingyun Yu
- Tianzhou Shen
- Qingan Fu
- Wei Zhou (ORCID: https://orcid.org/0000-0003-3901-6061)
- Yue Liu (ORCID: https://orcid.org/0000-0003-1200-3754)
- Jizhen Li (ORCID: https://orcid.org/0000-0002-8944-6353)
- Huanyi Zhu (ORCID: https://orcid.org/0000-0003-1193-467X)
- Zhekang Liu
Institutions
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Zhengzhou Central Hospital (CN)
Publication Details
- Journal
- Annals of General Psychiatry
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1186/s12991-025-00604-7
- Citations
- 1
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.81